Sapropterin Dihydrochloride Powder, For Solution
Product Images NDC 52817-851

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Sapropterin Dihydrochloride (NDC 52817-851). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Trupharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Sapropterin Dihydrochloride 100mg Carton Label)

Packaging label for Sapropterin Dihydrochloride Powder for Oral Solution, 100 mg per single use packet. The label indicates 30 individual packets per carton, for prescription use only, and the labeler is TRUPHARMA, LLC. The design includes dosage form and strength details along with a barcode and regulatory information.*

FDA Label Image

Image Description (Sapropterin Dihydrochloride 100mg Container Label)

Packaging label for Sapropterin Dihydrochloride Powder for Oral Solution, 100 mg single use packet, by TruPharma, LLC. The label includes usage instructions, drug name, strength, and the NDC 52817-850-01. The packet is designed for oral administration and is prescription only.*

FDA Label Image

Image Description (Sapropterin Dihydrochloride 500mg Carton Label)

Packaging label for Sapropterin Dihydrochloride Powder for Oral Solution, 500 mg per single-use packet. The carton contains 30 individual packets and is labeled for prescription use only. The labeler is TRUPHARMA, LLC. The NDC number printed is 52817-861-30.*

FDA Label Image

Image Description (Sapropterin Dihydrochloride 500mg Container Label)

Packaging label for Sapropterin Dihydrochloride Powder for Oral Solution by TRUPHARMA, LLC. The label specifies a strength of 500 mg per dose unit in a single-dose packet. The label includes product identification and usage instructions, presented on a narrow, rectangular packet layout with dimensional measurements.*

FDA Label Image

Image Description (Sapropterin Dihydrochloride Figure 1)

An instructional diagram showing an oral dosing syringe labeled with parts including barrel, tip, and plunger, alongside labeled medicine and water or apple juice cups. This figure demonstrates the tools used for dosing Sapropterin Dihydrochloride powder for solution orally.*

FDA Label Image

Image Description (Sapropterin Dihydrochloride Figure 2)

An instructional illustration showing a liquid being poured into a medicine cup. The image highlights the 'liquid line' inside the cup, indicating the measurement level for the liquid.*

FDA Label Image

Image Description (Sapropterin Dihydrochloride Figure 3)

An instructional illustration showing a hand pouring powder from a small packet into a medicine cup. The image demonstrates how to prepare a dose of oral powder, likely Sapropterin Dihydrochloride, for solution and administration.*

FDA Label Image

Image Description (Sapropterin Dihydrochloride Figure 4)

Illustration showing a hand stirring a liquid in a medicine cup with a spoon, labeled 'medicine cup.' This instructional diagram likely demonstrates how to mix or dissolve a powder formulation before oral administration.*

FDA Label Image

Image Description (Sapropterin Dihydrochloride Figure 5)

An instructional illustration showing a hand holding a syringe vertically and drawing liquid from a small medicine cup. The cup is labeled "medicine cup." This image likely demonstrates proper use or measurement of a liquid medication dose.*

FDA Label Image

Image Description (Sapropterin Dihydrochloride Figure 6)

An instructional diagram showing a hand holding a dosing syringe with labeled parts including the tip and liquid line. The syringe has measurement markings displayed along its side.*

FDA Label Image

Image Description (Sapropterin Dihydrochloride Figure 7)

A black-and-white instructional illustration showing a child receiving oral medication via a syringe, held by an adult. The image demonstrates proper administration technique using a dosing syringe to deliver liquid medication into the child's mouth.*

FDA Label Image

Image Description (Sapropterin Dihydrochloride Graph 2)

A line graph showing blood phenylalanine (Phe) levels (μmol/L) over several study visits from week -2 to week 6. Two lines compare Sapropterin Dihydrochloride (solid circles) and a control (open circles), indicating a significant decrease in blood Phe levels in the Sapropterin group. Error bars represent variability, and a p-value of less than 0.001 is noted.*

FDA Label Image

Image Description (Sapropterin Dihydrochloride Graph)

A line graph showing blood phenylalanine (Phe) levels in micromoles per liter (µmol/L) over time during a study visit. It compares two age groups, 1 month to under 2 years and 2 to under 7 years, with corresponding solid and dashed lines respectively, including error bars. The graph also highlights a target blood Phe control range with dotted lines.*

FDA Label Image

Image Description (Sapropterin Dihydrochloride Structure)

Chemical structure of Sapropterin Dihydrochloride showing the molecular arrangement including hydroxyl groups, amine groups, and methyl substituent, with a notation indicating the presence of two hydrochloride (HCl) units.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.